StockData

Shattuck Labs vs Yarrow Bioscience

STTK and YARW side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How STTK and YARW compare

Shattuck Labs is the larger company, worth 2.3 times as much as Yarrow Bioscience ($467M against $207M).

Yarrow Bioscience grew revenue faster over the last twelve months (13.8% versus −100% for Shattuck Labs).

Yarrow Bioscience pays a dividend yielding 112%; Shattuck Labs does not pay one.

Yarrow Bioscience scores higher on the StockData Score (13 against 8 for Shattuck Labs), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricSTTKYARW
Size and price
Market cap$467M$207M
Share price$4.65$18.03
Change, 1 year142%2.4%
Change, 5 years−50.5%−98.1%
Beta (5Y)1.611.55
Employees4010
StockData Score
Total score813 (better)
Valuation score01 (better)
Growth score11
Performance score12 (better)
Health score66
Dividend score03 (better)
Valuation
P/S–363×
P/B2.4×0.8× (better)
FCF yield–−16.0%
Growth
Revenue growth (TTM)−100%13.8% (better)
Revenue growth, 5Y average−36.8% (better)−51.4%
Profitability
Operating margin–−5219%
Net margin–−4646%
FCF margin–−5811%
Return on equity−47.2%−16.6% (better)
Return on invested capital−2531%–
Financial health
Debt / equity0.000.00
Current ratio15.8042.08 (better)
Altman Z-score16.2419.42 (better)
Piotroski F-score4 (better)3
Dividends and buybacks
Dividend yield–112%
Buyback yield−21.6%–
Shareholder yield−21.6%112% (better)
Ownership
Held by institutions83.5%2.7%
Held by insiders24.1%19.1%
Insider net buying, 12 months−$342K–
Short interest, % of float14.1%1.5%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.